Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Everest Biolabs receives $2.1M SBIR grant from NIH to expand R&D operations.

PRIVATESep 25, 2026

Amount Raised

$2.1 Million

Round Type

Seed

WalthamBiotechnologyHealth CareLife Science

Investors

National Institutes Of Health (Nih)National Institute Of General Medical Sciences (Nigms)

Description

Everest Biolabs, a Waltham, MA-based provider of automated extracellular vesicle isolation and analytics solutions, received a $2.1M Small Business Innovation Research (SBIR) Direct-to-Phase II grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH). The company plans to use the funds to expand operations and R&D efforts. Everest Biolabs provides automated, high-throughput tools for EV research and isolation, enabling researchers to cleanly isolate EVs from complex biofluids.

Company Information

Company

Everest Biolabs

Location

Waltham, Massachusetts, United States

About

Everest Biolabs is a life sciences company committed to providing essential tools for extracellular vesicle (EV) and exosome research. They focus on automating EV isolation and delivering standardized analytical tools to enhance researchers' workflows. Their innovative products aim to simplify and scale the research process, enabling scientists to focus on advancing clinical applications. With a mission to unlock the potential of EVs in clinical settings, Everest Biolabs upholds a strong commitment to innovation and scientific integrity.

Fundz sees it the moment Everest Biolabs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsTal G., Co-Founder and Head of Research hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Everest Biolabs's next move

See what Strategic adds

Everest Biolabs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.